Clinical trial · Observational
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
NCT01110733CI-TRIAL-00042724COMPLETEcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Peripheral T-cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patient is newly diagnosed with Peripheral T-cell Lymphoma (PTCL): * Aggressive natural killer (NK)-cell leukemia * Adult T-cell lymphoma/leukemia (human T-cell leukemia virus \[HTLV\] 1+) * Angioimmunoblastic T-cell lymphoma * Anaplastic large cell lymphoma (ALCL), primary systemic type (ALK+, ALK-) * PTCL, not otherwise specified (NOS) * T/NK-cell lymphoma, nasal type * Enteropathy-type intestinal lymphoma * Hepatosplenic T-cell lymphoma * Subcutaneous panniculitis T-cell lymphoma * Transformed mycosis fungoides (at diagnosis of transformation) * T-cell prolymphocytic leukemia (T-PLL) * Cutaneous gamma/delta (γ/δ) T-cell lymphoma * Cutaneous aggressive CD8+ T-cell lymphoma * Hematodermic neoplasms (blastic plasmacytoid dendritic cell neoplasm) * Systemic Epstein Barr Virus (EBV)+ T-cell lymphomas (T-cell lymphoproliferative disorders of childhood) * Other T-Cell lymphomas that are not listed in the Exclusion Criteria * Patient gives written informed consent Exclusion Criteria: * Patient has other T- or NK-cell malignancies including: * Precursor T/NK neoplasms * T-cell large granular lymphocytic leukemia * Mycosis fungoides, other than transformed mycosis fungoides * Sézary syndrome * Primary cutaneous CD30+ disorders: ALCL and lymphomatoid papulosis
References
Publications (0)
Data not yet available
No reference posted for this study.